CN1230172C - 血液循环改善剂 - Google Patents

血液循环改善剂 Download PDF

Info

Publication number
CN1230172C
CN1230172C CNB021439826A CN02143982A CN1230172C CN 1230172 C CN1230172 C CN 1230172C CN B021439826 A CNB021439826 A CN B021439826A CN 02143982 A CN02143982 A CN 02143982A CN 1230172 C CN1230172 C CN 1230172C
Authority
CN
China
Prior art keywords
blood circulation
agent
vitamin
improving agent
circulation improving
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB021439826A
Other languages
English (en)
Chinese (zh)
Other versions
CN1411811A (zh
Inventor
冈田実
末广义兴
坂井裕贵
今森胜美
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SSP Co Ltd
Original Assignee
SSP Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SSP Co Ltd filed Critical SSP Co Ltd
Publication of CN1411811A publication Critical patent/CN1411811A/zh
Application granted granted Critical
Publication of CN1230172C publication Critical patent/CN1230172C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Medicinal Preparation (AREA)
CNB021439826A 2001-10-11 2002-09-29 血液循环改善剂 Expired - Fee Related CN1230172C (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP314228/2001 2001-10-11
JP2001314228A JP2003119135A (ja) 2001-10-11 2001-10-11 血行改善薬

Publications (2)

Publication Number Publication Date
CN1411811A CN1411811A (zh) 2003-04-23
CN1230172C true CN1230172C (zh) 2005-12-07

Family

ID=19132579

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB021439826A Expired - Fee Related CN1230172C (zh) 2001-10-11 2002-09-29 血液循环改善剂

Country Status (4)

Country Link
JP (1) JP2003119135A (https=)
KR (1) KR20030030867A (https=)
CN (1) CN1230172C (https=)
TW (1) TWI262074B (https=)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4612194A (en) * 1984-02-15 1986-09-16 Roshdy Ismail Anti-rheumatic agents and their use
JPS61277609A (ja) * 1985-06-01 1986-12-08 Mikasa Kagaku Kogyo Kk 入浴剤
JPS62123108A (ja) * 1985-11-21 1987-06-04 Kanebo Ltd 養毛化粧料
JPS62123105A (ja) * 1985-11-21 1987-06-04 Kanebo Ltd 皮膚化粧料
KR930019221A (ko) * 1992-03-02 1993-10-18 이승철 성인병 예방 및 치료용 순환계용계약 조성물
US5811547A (en) * 1992-10-14 1998-09-22 Nippon Shinyaju Co., Ltd. Method for inducing crystalline state transition in medicinal substance

Also Published As

Publication number Publication date
JP2003119135A (ja) 2003-04-23
HK1054696A1 (en) 2003-12-12
CN1411811A (zh) 2003-04-23
TWI262074B (en) 2006-09-21
KR20030030867A (ko) 2003-04-18

Similar Documents

Publication Publication Date Title
DE60221691T3 (de) Tamsulosin tabletten ohne nahrungsmitteleffekt
KR100549473B1 (ko) 플루옥세틴 장용성 펠렛
DE69623634T2 (de) Pharmazeutische zusammensetzung von l-dopa ethyl ester
EP0857064B1 (de) Stabilisierte schilddrüsenhormonhaltige arzneimittel
JPWO2001015702A1 (ja) 軟カプセル剤
US20240156761A1 (en) Magnesium Threonate Compositions and Uses Thereof
KR102306138B1 (ko) 고 약물 부하량의 중쇄 트리글리세라이드를 갖는 약학 조성물 및 이와 관련된 방법
JP7827696B2 (ja) トリフェニルカルシリティック化合物の製剤
DE19710054A1 (de) Pharmazeutische Zubereitung
CN1230172C (zh) 血液循环改善剂
EP2161022B1 (de) Herstellung von Phosphatbindern und auf diese Weise hergestellte Phosphatbinder
CN105362242A (zh) 一种依普利酮分散片
JP2000247879A (ja) ビタミン製剤
JP2008201712A (ja) フィルムコーティング製剤
HK1054696B (en) Blood circulation improving preparation
CN1244326C (zh) 抗疲劳药物组合物
CZ146494A3 (en) Ipsapirone healing preparation
JPH0569089B2 (https=)
US4499106A (en) Lipolytic composition and method of treating obesity
JPH0317016A (ja) 神経系症状の処置剤
JPH0570352A (ja) 医薬組成物
JPH09241171A (ja) 抗アレルギー、抗炎症剤
JPH1087501A (ja) 末梢血流改善剤
HK1092734A1 (en) Oral formulation for twice-daily administration
JPH09165340A (ja) 末梢血流改善、異常知覚改善剤

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20051207

Termination date: 20091029